Thermo Fisher will drop a whopping $600M into its manufacturing supply chain as Covid-19 work ramps up
With Covid-19 contract work growing at a rapid clip, the biggest CDMOs are taking the opportunity — and a windfall of cash — to carve out bigger footprints. At Thermo Fisher Scientific, the time’s never been better for a farsighted global expansion that will greatly expand its manufacturing capacity and add redundancy to the supply chain.
Thermo will pump $600 million into its global manufacturing network as part of a move to ramp up its short-term Covid-19 work and more than double its capacity for the future, the Massachusetts firm said Wednesday.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.
